Navigation Links
AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
Date:5/7/2008

- -

Net loss per share

Basic and diluted (0.20) (0.10)

Weighted average number of shares

Basic and diluted 53,187,470 53,179,470

(In thousands of US dollars, except share

and per share data)

CONSOLIDATED BALANCE SHEETS

Unaudited March 31, December 31,

2008 2007

-------------------------------------------------------------------------

-------------------------------------------------------------------------

$ $

Cash and short-term investments 38,714 41,387

Other current assets 18,527 18,193

-----------------------

57,241 59,580

Long-term assets 60,281 63,783

-----------------------

Total assets 117,522 123,363

-----------------------

-----------------------

Current liabilities 26,135 22,255

Other long-term liabilities 13,354 12,517

-----------------------

39,489 34,772

Shareholders' equity 78,033 88,591

-----------------------

Total liabilities and sharehol
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharma...mark Office (PTO) has allowed the patent applicati...nology. , NOD technology is a highly effi... into bio-adhesive nano-particles to enable oral d...ons. NOD technology is a platform technology,that ...
(Date:11/24/2009)...E, Nov. 24 Blue Marble Energy Corp...Public Development Authority (OPDA) were recently ... Economic Revitalization Board (CERB) in a private... specialty biochemical biorefinery in Lincoln Coun...y speed the development of our biorefinery and bri...
(Date:11/24/2009)...ENTURE: HTL , TORONTO, Nov. 24 /PRNewswire-Fi...erly Calotto Capital Inc., a leading provider of a... cell research and fertility clinic markets, today...e third quarter ended September 30, 2009. , , ...ion compared with $1.43 million in Q3 2008, - ...
(Date:11/24/2009)...OOD CITY, Calif., Nov. 24 /PRNewswire-FirstCall/ -...unced that Randy Scott, Genomic Health,s Executive...affray Health Care Conference in New York City on ... To access the live and subsequently archived webc...ons section of Genomic Health,s website at http:/...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ne 17 MedPredict has published a,new report desig...ma and,biotech companies with a stake in the marke...rea. The report, entitled "Thought Leader Insight ...epth interviews conducted,with a panel of physicia...earch., "There is some real progress being made i...
... June 17 , - First World Allergy Report Calls for...ncrease in Allergies and Allergic Diseases, The W...irst Report on,the extent of allergy and chronic r...and has called for immediate collaboration to tack... last 20-30 years, the prevalence of,allergic dise...
...rst Comprehensive and Quality Assured Biomarker ...ndustry, PHILADELPHIA and LONDON, June 17 Thomso...nt information for,businesses and professionals, a...ique comprehensive resource for biomarker,intellig...de the,pharmaceutical industry with a framework fo...
Other Biology Technology:Thought Leaders Discuss Positive Outlook for Bapineuzumab in Alzheimer's Disease in MedPredict Report 2World Allergy Organization Highlights Global Allergy Impact 2Thomson Reuters Launches New Biomarkers Solution 2
(Date:11/24/2009)...n College of Medical Toxicology (ACMT) have signed... the Journal of Medical Toxicology (JMT), the of...0. It was previously published by the University ...l Toxicology , an international, peer-reviewed jou...actice of medical toxicology. The quarterly journ...
(Date:11/24/2009)... 24, 2009) New research on bacterial communities ...ls predictable temporal patterns, suggesting that ...for monitoring climate change in the polar regions...gs of the National Academy of Sciences Early Edit...ivers shifted synchronously over time, correlating...
(Date:11/23/2009)...vember 23, 2009 Applied mathematicians dissected ...olia ), a characteristic long leaf with a saddle-l...g the edges. The simple cause of the lily,s fan-li...during differential growthwas revealed by using an.... , Haiyi Liang, a postdoctoral student at Harva...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2West to Host 2009 Second Quarter Conference Call 52897 1West to Host 2009 Second Quarter Conference Call 52897 2Emdeon Inc Commences U S Initial Public Offering of Class A Common Stock 52893 1Emdeon Inc Commences U S Initial Public Offering of Class A Common Stock 52893 2Emdeon Inc Commences U S Initial Public Offering of Class A Common Stock 52893 3GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 1GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 2
..., Richard B. Sher, PhD, a professor of history at... a National Endowment for the Humanities (NEH) Fel...James Boswell, the eighteenth-century Scottish wri...amuel Johnson. Sher,s research focuses on the th...e University Press will publish the book in its Re...
..., Montreal, February 5, 2009 It,s not uncommon f...heir concentration as they study throughout the ni...tion," says Stphanie Ct, nutritionist with Extenso...k-tank. "These drinks are made up of sugar and caf... According to a 2008 report by Agriculture and Ag...
..., A team of researchers are reporting the ongoing...sequential development of a new species of wasp--i... Jeff Feder, a University of Notre Dame biologist...s to America almost 400 years ago ultimately may h...o its modification and the subsequent modification...
Other Biology News:Researchers observe evolution chain reaction 2
Rabbit IgG ELISA Development Kit, SensiFlex with Fluorocillin Green 495/525 from Molecular Probes (Invitrogen)
Bovine BSA, Fluorescein conjugated/tagged from Biosearch Technologies
Sheep Anti-Human CORTISOL BINDING GLOBULIN Polyclonal Antibody, Unconjugated from AbD Serotec
Eosinophil IHC Staining Kit, EoProbe from BioFX Laboratories, Inc.
Biology Products: